Lepu Medical desarrolla reactivos cuantitativos fluorométricos para detectar el virus de la monkeypox
-
2022-08-11
-
LEPU
According to the WHO news announcement, the monkeypox epidemic has found about 26,000 confirmed cases of monkeypox in more than 88 countries and regions, constituting the highest level of alert of "public health event of international concern (PHEIC)"! This has raised concerns about the spread of the virus. According to the WHO, Europe is currently a high-risk area for monkeypox, and the rest of the world is at a medium-risk level.
En respuesta al brote mundial de viruela del mono, Lepu Medical desarrolló un kit de prueba de ácido nucleico (PCR-Método de sonda de fluorescencia) para el virus de la viruela del mono y obtuvo la certificación CE de la UE. Este reactivo proporciona una solución para ayudar a los laboratorios en varios países a realizar de manera eficiente las pruebas de ácido nucleico de la viruela del mono y el diagnóstico rápido.
Lepu Medical's monkeypox virus detection kit has the characteristics of high detection sensitivity, easy operability and strong stability. The kit can be quickly applied on multiple platforms such as Lepgen-96, Roche LightCycler 480 series, Bio-Rad CFX96, Shanghai Hongshi SLAN, and ABI 7500. At present, Lepu Medical has received orders and inquiries from many overseas countries and, at the same time, actively promotes the registration of this product in other overseas countries.
